| Nov 21 |
Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference
|
| Nov 18 |
Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024
|
| Nov 13 |
Esperion Therapeutics: Growth Initiatives Are Paying Off - Buy
|
| Nov 8 |
Esperion Therapeutics Inc (ESPR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...
|
| Nov 7 |
Esperion Therapeutics, Inc. (ESPR) Q3 2024 Earnings Call Transcript
|
| Nov 7 |
Esperion's Q3 Loss Wider Than Expected, Revenues Rise Y/Y
|
| Nov 7 |
Esperion Therapeutics (ESPR) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 7 |
Esperion Therapeutics: Q3 Earnings Snapshot
|
| Nov 7 |
Esperion Therapeutics gives mixed Q3 results
|
| Nov 7 |
Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update
|
